Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cholebrine
2. N-acetyl-n-(3-amino-2,4,6-triiodophenyl)-2-methyl-beta-alanine
1. Cholebrine
2. 16034-77-8
3. Mp-620
4. 3-(n-acetyl-3-amino-2,4,6-triiodoanilino)-2-methylpropanoic Acid
5. Fa675q0e3e
6. Propanoic Acid, 3-(acetyl(3-amino-2,4,6-triiodophenyl)amino)-2-methyl-
7. Cholimil
8. Colebrina
9. Iocetamic Acid (usan)
10. 3-(n-(3-amino-2,4,6-triiodophenyl)acetamido)-2-methylpropanoic Acid
11. 3-[acetyl(3-amino-2,4,6-triiodophenyl)amino]-2-methylpropanoic Acid
12. Acidum Jocetamicum
13. Cholimil; Drc 1201; Iocetamic Acid; Mp 620
14. Iocetamic Acid [usan]
15. Acido Iocetamico
16. Acide Iocetamique
17. Acidum Iocetamicum
18. Acide Iocetamique [inn-french]
19. Acido Iocetamico [inn-spanish]
20. Acidum Iocetamicum [inn-latin]
21. Hsdb 3344
22. Drc 1201
23. Einecs 240-173-1
24. Mp 620
25. Brn 2171366
26. Unii-fa675q0e3e
27. Cholebrine (tn)
28. Ncgc00016720-01
29. Cas-16034-77-8
30. Iocetamic Acid [usan:usp:inn:ban]
31. Starbld0009604
32. Beta-alanine, N-acetyl-n-(3-amino-2,4,6-triiodophenyl)-2-methyl-
33. N-acetyl-n-(3-amino-2,4,6-triiodophenl)-2-methyl-beta-alanine
34. N-acetyl-n-(3-amino-2,4,6-triiodophenyl)-2-methyl-beta-alanine
35. Prestwick0_000838
36. Prestwick1_000838
37. Prestwick2_000838
38. Prestwick3_000838
39. 3-(acetyl-(3-amino-2,4,6-triiodophenyl)amino)-2-methylpropanoic Acid
40. Dsstox_cid_3149
41. N-acetyl-n-(2,4,6-triiodo-3-aminophenyl)-beta-aminoisobutyric Acid
42. N-acetyl-n-(3-amino-2,4,6-triiodophenyl)-beta-aminoisobutyric Acid
43. Propionic Acid, 3-(acetyl-(3-amino-2,4,6-triiodophenyl)amino)-2-methyl-
44. Dsstox_rid_76891
45. Iocetamic Acid [mi]
46. Dsstox_gsid_23149
47. Schembl38499
48. Bspbio_000795
49. Iocetamic Acid [inn]
50. Mls002154025
51. Iocetamic Acid [hsdb]
52. Spbio_002716
53. Iocetamic Acid [vandf]
54. Bpbio1_000875
55. Iocetamic Acid [mart.]
56. Chembl1200770
57. Dtxsid2023149
58. Iocetamic Acid [who-dd]
59. Chebi:91662
60. Hms1570h17
61. Hms2097h17
62. Hms2234p18
63. Hms3373o18
64. Hms3714h17
65. Tox21_110580
66. Iocetamic Acid [orange Book]
67. Ccg-220838
68. Db09403
69. Ncgc00179430-01
70. Ncgc00179430-04
71. Smr001233352
72. Ab00513935
73. D04563
74. Sr-01000838894
75. Q6062203
76. Sr-01000838894-2
77. Brd-a37492983-001-03-8
78. N-acetyl-n-(3-amino-2,4,6-triiodophenyl)-2-methyl-.beta.-alanine
| Molecular Weight | 613.96 g/mol |
|---|---|
| Molecular Formula | C12H13I3N2O3 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 613.8060 g/mol |
| Monoisotopic Mass | 613.8060 g/mol |
| Topological Polar Surface Area | 83.6 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 383 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Contrast Media
National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)
AN ORAL CHOLECYSTOGRAPHIC AGENT INDICATED FOR RADIOGRAPHIC VISUALIZATION OF GALL BLADDER. ... CONTRACTION OF GALL BLADDER ALSO MAY PROVIDE VISUALIZATION OF BILIARY DUCTS.
Osol, A. (ed.). Remington's Pharmaceutical Sciences. 16th ed. Easton, Pennsylvania: Mack Publishing Co., 1980., p. 1214
TYROPANOATE 3 G, IOCETAMIC ACID 4.5 G, IOPANOIC ACID 3 G & IOCETAMIC ACID 3 G, WERE EVALUATED IN 800 PT. IOCETAMIC ACID IS AS RELIABLE & EFFECTIVE AS TYROPANOATE OR IOPANOIC ACID IN CHOLECYSTOGRAPHY. 3 G DOSE PRODUCES CHOLECYSTOGRAMS AS SATISFACTORY AS 4.5 G WITH LOWER INCIDENCE OF CRAMPS.
PARKS R; DOUBLE-BLIND STUDY OF 4 ORAL CHOLECYSTOGRAPHIC PREPARATIONS; RADIOLOGY 112(SEP) 525 (1974)
IT IS CONTRAINDICATED IN PT WITH ACUTE NEPHRITIS AND UREMIA, SINCE IT IS ELIMINATED BY THE KIDNEYS. IT SHOULD NOT BE ADMIN WHEN DISORDERS OF THE GI TRACT EXIST WHICH PREVENT ABSORPTION OF THE MEDIUM.
Osol, A. (ed.). Remington's Pharmaceutical Sciences. 16th ed. Easton, Pennsylvania: Mack Publishing Co., 1980., p. 1214
V - Various
V08 - Contrast media
V08A - X-ray contrast media, iodinated
V08AC - Watersoluble, hepatotropic x-ray contrast media
V08AC07 - Iocetamic acid
...RAPIDLY ABSORBED FOLLOWING ORAL ADMIN, CONJUGATED WITH GLUCURONIC ACID IN LIVER, SECRETED INTO BILE AS RADIOPAQUE GLUCURONIDE, & CONCN IN THE FUNCTIONING GALL BLADDER.
Osol, A. (ed.). Remington's Pharmaceutical Sciences. 16th ed. Easton, Pennsylvania: Mack Publishing Co., 1980., p. 1214
...CONJUGATED WITH GLUCURONIC ACID IN LIVER...
Osol, A. (ed.). Remington's Pharmaceutical Sciences. 16th ed. Easton, Pennsylvania: Mack Publishing Co., 1980., p. 1214
ABOUT THIS PAGE
62
PharmaCompass offers a list of Iocetamic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Iocetamic Acid manufacturer or Iocetamic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Iocetamic Acid manufacturer or Iocetamic Acid supplier.
PharmaCompass also assists you with knowing the Iocetamic Acid API Price utilized in the formulation of products. Iocetamic Acid API Price is not always fixed or binding as the Iocetamic Acid Price is obtained through a variety of data sources. The Iocetamic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_3149 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_3149, including repackagers and relabelers. The FDA regulates DSSTox_CID_3149 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_3149 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A DSSTox_CID_3149 supplier is an individual or a company that provides DSSTox_CID_3149 active pharmaceutical ingredient (API) or DSSTox_CID_3149 finished formulations upon request. The DSSTox_CID_3149 suppliers may include DSSTox_CID_3149 API manufacturers, exporters, distributors and traders.
DSSTox_CID_3149 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_3149 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_3149 GMP manufacturer or DSSTox_CID_3149 GMP API supplier for your needs.
A DSSTox_CID_3149 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_3149's compliance with DSSTox_CID_3149 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_3149 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_3149 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_3149 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_3149 EP), DSSTox_CID_3149 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_3149 USP).
